Inactive Instrument

OTR ACQU Stock

OTRA

US67113Q1058

OTR Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company is not engaged in any business operations. The Company has not generated revenue.

Employees

Sector

More about the company

22-05-20	Comera Life Sciences Starts Trading on Nasdaq After SPAC Deal; Shares Rise	MT
22-05-19	OTR Acquisition Corp.(NasdaqCM:OTRA) dropped from NASDAQ Composite Index	CI
22-05-18	Comera Life Sciences, Inc. completed the acquisition of OTR Acquisition Corp. from OTR Acquisition Sponsor LLC, Karpus Management Inc, Polar Asset Management Partners Inc., Hudson Bay Capital Management LP and others in a reverse merger transaction.	CI
22-05-13	OTR Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
22-05-13	Top Premarket Gainers	MT
22-03-08	OTR Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	CI
22-03-07	OTR Acquisition Corp. Auditor Raises 'Going Concern' Doubt	CI
22-02-28	OTR Acquisition Corp. announced that it expects to receive $0.5 million in funding from OTR Acquisition Sponsor LLC	CI
22-01-31	OTR Acquisition to Take Comera Life Sciences Public in Merger Deal	MT
22-01-30	Comera Life Sciences, Inc. entered into a letter of intent to acquire OTR Acquisition Corp. from OTR Acquisition Sponsor LLC, Karpus Management Inc, Polar Asset Management Partners Inc., Hudson Bay Capital Management LP and others in a reverse merger transaction for approximately $130 million.	CI
21-11-08	OTR Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	CI
21-08-04	OTR Acquisition Corp. Announces Board Changes	CI
21-08-03	Otr Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	CI

22-05-24	OTR ACQU : Comera Life Sciences Debuts as Publicly Traded Company Focused on Transforming Biologics - Form 8-K	PU
22-05-20	Comera Life Sciences Debuts as Publicly Traded Company Focused on Transforming Biologics	BU
22-05-18	OTR ACQUISITION CORP. : Other Events (form 8-K)	AQ
22-05-16	OTR ACQUISITION CORP. : Other Events (form 8-K)	AQ
22-05-13	OTR ACQUISITION CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ

Date	Insider	Type	Main position	Quantity	% Market Cap.
5/20/22	OTR Acquisition Sponsor LLC	Conversion	Company	1,305,918	48.8194%
5/20/22	Nicholas Singer	Others	Chief Executive Officer; Director	1,727,677	64.5861%
5/19/22	Nadav Besner	Conversion	Director	5,000	0.1869%

OTR ACQU Stock

Stocks

OTRA

US67113Q1058

Latest news : OTR ACQU

Press Releases : OTR ACQU

Quotes and Performance

Latest insider transactions

Company Profile